Lansoprazole vs Omeprazole for GERD

Initial Treatment Approach

The American College of Physicians recommends that either lansoprazole or omeprazole can be used as first-line therapy for typical GERD symptoms, as absolute differences in efficacy for symptom control and tissue healing are small between all PPIs 1, 2
For patients presenting with typical GERD symptoms without alarm features, empirical acid-suppressive therapy with once-daily PPI is warranted without endoscopy, according to the American College of Physicians 1, 2
Any PPI may be selected, including omeprazole, lansoprazole, esomeprazole, pantoprazole, rabeprazole, or dexlansoprazole, as absolute differences in efficacy are small, as stated by the American College of Physicians 1, 2
PPIs should be taken 30-60 minutes before a meal for optimal efficacy, as recommended by the American College of Physicians 1, 2

If once-daily therapy fails to control symptoms adequately, escalate to twice-daily dosing of the same PPI before switching agents, according to the American College of Physicians 1, 2, 3
If 4-8 weeks of twice-daily PPI therapy is unsuccessful, further investigation with endoscopy is recommended, as stated by the American College of Physicians 1, 2

Do not use subtherapeutic doses, as standard doses are omeprazole 20 mg or lansoprazole 30 mg, and lower doses show reduced efficacy, according to the European Society of Gastrointestinal Endoscopy 4
Ensure proper timing, as PPIs must be taken 30-60 minutes before meals, not at bedtime or with meals, as recommended by the American College of Physicians 1, 2
Do not switch PPIs prematurely, as escalate to twice-daily dosing of the initial agent before switching to a different PPI, according to the American College of Physicians 1, 2, 3
Recognize alarm symptoms, such as dysphagia, bleeding, anemia, weight loss, or recurrent vomiting, which mandate endoscopy regardless of PPI response, as stated by the American College of Physicians 1, 2

Patients typically experience initial symptom relief from PPIs within 5-7 days, with maximal therapeutic effect achieved after 4 weeks of continuous therapy 5, 6
Heartburn response during days 5-7 of the first week is the most discriminating predictor of treatment outcome 5, 6
Of patients who are heartburn-free during days 5-7 of treatment, 85% remain heartburn-free at 4 weeks 5, 6
Conversely, patients with persistent moderate or severe heartburn every day during days 5-7 have only a 22% chance of being heartburn-free at 4 weeks 5, 6

For extraesophageal reflux (EER) symptoms such as chronic cough or laryngitis, an 8-12 week trial of twice-daily PPI is required before assessing response 7, 8
For eosinophilic esophagitis, PPIs should be given twice daily for at least 8-12 weeks prior to assessment of histological response 9
If once-daily therapy fails after 4 weeks for EER symptoms, 54% of patients showed symptom improvement after an additional 8 weeks of twice-daily PPI 7, 8

Do not assess treatment failure before completing at least 4 weeks of properly timed PPI therapy 5, 6
Lack of response at 1 week does not necessarily predict treatment failure at 4 weeks - some patients require longer therapy to achieve symptom control 5, 6